These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 20513366)

  • 1. Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.
    Die J; Wang K; Fan L; Jiang Y; Shi Z
    Brain Res; 2010 Jul; 1346():251-61. PubMed ID: 20513366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts.
    Di Napoli P; Taccardi AA; Grilli A; De Lutiis MA; Barsotti A; Felaco M; De Caterina R
    Cardiovasc Res; 2005 Jun; 66(3):462-71. PubMed ID: 15914111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin, a new generation 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces ischemia/reperfusion-induced spinal cord tissue injury in rats.
    Ucak A; Onan B; Güler A; Sahin MA; Kılıçkaya O; Oztaş E; Uysal B; Arslan S; Yılmaz AT
    Ann Vasc Surg; 2011 Jul; 25(5):686-95. PubMed ID: 21724106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of neuronal and inducible nitric oxide synthase in the motoneurons of spinal cord following transient abdominal aorta occlusion in rats.
    Zhou Y; Zhao YN; Yang EB; Ling EA; Wang Y; Hassouna MM; Mack P
    J Surg Res; 1999 Dec; 87(2):185-93. PubMed ID: 10600348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
    J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.
    Kilic U; Bassetti CL; Kilic E; Xing H; Wang Z; Hermann DM
    Neuroscience; 2005; 134(3):901-6. PubMed ID: 16009498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
    Zhang JH; Chen ZW; Wu Z
    Can J Physiol Pharmacol; 2008 Mar; 86(3):131-8. PubMed ID: 18418440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
    Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H
    J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells.
    Landsberger M; Jantzen F; Könemann S; Felix SB
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1005-9. PubMed ID: 16165089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
    Sironi L; Gianazza E; Gelosa P; Guerrini U; Nobili E; Gianella A; Cremonesi B; Paoletti R; Tremoli E
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):598-603. PubMed ID: 15681303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. eNOS/Hsp70 interaction on rosuvastatin cytoprotective effect in neonatal obstructive nephropathy.
    Manucha W; Kurbán F; Mazzei L; Benardón ME; Bocanegra V; Tosi MR; Vallés P
    Eur J Pharmacol; 2011 Jan; 650(2-3):487-95. PubMed ID: 20940012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose rosuvastatin ameliorates lung ischemia-reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage infiltration in rats with pulmonary hypertension.
    Matsuo S; Saiki Y; Adachi O; Kawamoto S; Fukushige S; Horii A; Saiki Y
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):902-9. PubMed ID: 25454916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of spinal cord ischemia/reperfusion injury with simvastatin in rats.
    Saito T; Tsuchida M; Umehara S; Kohno T; Yamamoto H; Hayashi J
    Anesth Analg; 2011 Sep; 113(3):565-71. PubMed ID: 21680858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional protection of pentoxifylline against spinal cord ischemia/reperfusion injury in rabbits: necrosis and apoptosis effects.
    Zhu DJ; Xia B; Bi Q; Zhang SJ; Qiu BS; Zhao C
    Chin Med J (Engl); 2008 Dec; 121(23):2444-9. PubMed ID: 19102966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of nitric oxide synthase isoforms in the dorsal horn of monoarthritic rats: effects of competitive and uncompetitive N-methyl-D-aspartate antagonists.
    Infante C; Díaz M; Hernández A; Constandil L; Pelissier T
    Arthritis Res Ther; 2007; 9(3):R53. PubMed ID: 17521446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.
    Bulhak AA; Gourine AV; Gonon AT; Sjöquist PO; Valen G; Pernow J
    Acta Physiol Scand; 2005 Feb; 183(2):151-9. PubMed ID: 15676056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells.
    Kim YS; Ahn Y; Hong MH; Kim KH; Park HW; Hong YJ; Kim JH; Kim W; Jeong MH; Cho JG; Park JC; Kang JC
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):376-83. PubMed ID: 17577102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin changes cytokine expressions in ischemic territory and preserves heart function after acute myocardial infarction in rats.
    Hu X; Sun A; Xie X; Huang Z; Jia J; Yao R; Ge J
    J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):162-76. PubMed ID: 23139358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOS upregulation attenuates vascular endothelial dysfunction in the late phase of ischemic preconditioning in skeletal muscle.
    Wang WZ; Fang XH; Stepheson LL; Khiabani KT; Zamboni WA
    J Orthop Res; 2004 May; 22(3):578-85. PubMed ID: 15099638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.
    Laufs U; Gertz K; Dirnagl U; Böhm M; Nickenig G; Endres M
    Brain Res; 2002 Jun; 942(1-2):23-30. PubMed ID: 12031849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.